Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Multicenter, Randomized, Double-Blind, Parallel Group Study to Investigate the Efficacy and Safety of Omega-3-acid Ethyl Ester Over 12 Weeks in Chinese Subjects With Hypertriglyceridemia

NCT04756180 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT04756180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04756180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Multicenter, Randomized, Double-Blind, Parallel Group Study to Investigate the Efficacy and Safety of Omega-3-acid Ethyl Ester Over 12 Weeks in Chinese Subjects With Hypertriglyceridemia
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2016
Completion date
April 30, 2019
Enrollment
248 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia